🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Emi Takashita

National Institute of Infectious Diseases

ORCID: 0000-0002-9064-4699
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

Antiviral Research(2022)10.1016/j.antiviral.2022.105281
Top 4%
5.0DataRank
Top 4%143 citations

Emi Takashita, Rod S. Daniels, Seiichiro Fujisaki, Lance Presser, Mira C. Patel +16 more

Papers

Driven by 7 papers — median percentile 96. Top paper: “Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2”.

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

Nature(2022)10.1038/s41586-022-04856-1
N/A
10.7DataRank · unranked
293 citations

Maki Kiso, Shun Iida, Masaki Imai, Emi Takashita, Makoto Kuroda +64 more

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

Antiviral Research(2022)10.1016/j.antiviral.2022.105281
Top 4%
5.0DataRank
Top 4%143 citations

Emi Takashita, Rod S. Daniels, Seiichiro Fujisaki, Lance Presser, Mira C. Patel +16 more

Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group

Antiviral Research(2021)10.1016/j.antiviral.2021.105158
N/A
0DataRank · unranked
42 citations

Frederick G. Hayden, Alan Hay, Larisa V. Gubareva, Elena A. Govorkova, Emi Takashita +2 more

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

New England Journal of Medicine(2022)10.1056/nejmc2207519
N/A
0DataRank · unranked
323 citations

Seiya Yamayoshi, Viviana Simon, Harm van Bakel, Emilia Mia Sordillo, Andrew Pekosz +11 more

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018

Antiviral Research(2020)10.1016/j.antiviral.2020.104718
N/A
0DataRank · unranked
129 citations

Rod S. Daniels, Seiichiro Fujisaki, Vicki L. Gregory, Larisa V. Gubareva, Weiijuan Huang +13 more

Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters

Nature Microbiology(2022)10.1038/s41564-022-01170-4
N/A
0DataRank · unranked
39 citations

Maki Kiso, Masaki Imai, Seiya Yamayoshi, Mutsumi Ito, Seiichiro Fujisaki +10 more

Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023

Antiviral Research(2025)10.1016/j.antiviral.2025.106217
N/A
0DataRank · unranked
17 citations

Adam Meijer, Elena A. Govorkova, Clyde Dapat, Larisa V. Gubareva, Ian Barr +20 more